Aspira Women's Health, Inc. (AWH)
| Market Cap | 623.48M |
| Revenue (ttm) | 4.51M |
| Net Income (ttm) | -15.21M |
| Shares Out | 103.20M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 20 |
| Last Price | $5.98 |
| Previous Close | $6.08 |
| Change ($) | -0.11 |
| Change (%) | -1.73% |
| Day's Open | 6.09 |
| Day's Range | 5.74 - 6.24 |
| Day's Volume | 604,273 |
| 52-Week Range | 0.64 - 6.71 |
These winners are positioned for gains even after COVID.
Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and Biotech Showcase™ from January 6 – 15 th , 2021
AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the ...
Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET
Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET
AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for...
AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company focused on gynecologic disease, today annou...
Vermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including corona...
AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its...
AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set ...
Vermillion's (VRML) CEO Valerie Palmieri on Q1 2020 Results - Earnings Call Transcript
Conference Call scheduled for today, May 14th at 4:30 p.m. ET Conference Call scheduled for today, May 14th at 4:30 p.m. ET
Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2019 Results - Earnings Call Transcript
Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q3 2019 Results - Earnings Call Transcript
Vermillion's (VRML) CEO Valerie Palmieri on Q2 2019 Results - Earnings Call Transcript
Vermillion's (VRML) CEO Valerie Palmieri on Q1 2019 Results - Earnings Call Transcript
Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2018 Results - Earnings Call Transcript
About AWH
Aspira Women's Health, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies ... [Read more...]
| Industry Diagnostics & Research | Founded 1993 |
| CEO Valerie Palmieri | Employees 52 |
| Stock Exchange NASDAQ | Ticker Symbol AWH |
Financial Performance
In 2019, AWH's revenue was $4.54 million, an increase of 48.64% compared to the previous year's $3.05 million. Losses were -$15.24 million, 34.0% more than in 2018.
Analyst Forecasts
The average 12-month stock price forecast for AWH is 8.00, which is an increase of 33.89% from the latest price.